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Prolonged increases in vein wall tension increase
matrix metalloproteinases and decrease
constriction in rat vena cava: Potential implications
in varicose veins
Joseph D. Raffetto, MD,c Xiaoying Qiao, MD, PhD,a Vera V. Koledova, MD, PhD,a and
Raouf A. Khalil, MD, PhD,a,b Boston and West Roxbury, Mass
Background: Increased venous hydrostatic pressure plays a role in the pathogenesis of varicose veins. Increased expression
of matrix metalloproteinases (MMPs) has been identified in varicose veins. Also, we have shown that MMP-2 inhibits
venous contraction. However, the relation between venous pressure,MMP expression, and venous dysfunction is unclear.
The purpose of this study was to test the hypothesis that prolonged increases in venous wall tension cause overexpression
of MMPs and decreased contractility, which in turn promote venous dilation.
Methods: Circular segments of inferior vena cava (IVC) were isolated frommale Sprague-Dawley rats and suspended between
twowires in Krebs solution. Preliminary veinwall tension-contraction relation showedmaximal potassium chloride (KCl) (96
mmol/L) contraction at 0.5 g basal tension, which remained steady with increases in tension up to 2 g. Vein segments were
subjected to either control (0.5 g) or high (2 g) basal tension for short (1 hour) or long duration (24 hours). Isometric
contraction in response to phenylephrine (Phe, 105 mol/L), angiotensin II (AngII, 106 mol/L), and KCl was measured.
The veins were frozen to determine the expression and localization ofMMPs using immunoblots and immunohistochemistry.
Results: In IVC segments subjected to 0.5 g tension for 1 hour, Phe andAngII produced significant contraction. At higher 2 g
basal tension for 24 hours, bothPhe andAngII contractionswere significantly reduced. Reduction inKCl contractionwas also
observed at high 2 g basal tension for 24 hours, suggesting that the reduction in vein contraction is not specific to a particular
receptor, and likely involves inhibition of a post-receptor contraction mechanism. In vein segments under 2 g tension for 24
hours and treated with TIMP-1, Phe, AngII, and KCl contractions were partially restored, suggesting the involvement of
MMPs. IVC immunoblot analysis demonstrated prominent bands corresponding to MMP-2 and MMP-9 protein. High 2 g
wall tension for 24 hours was associated with marked increase in the amount of MMP-2 and -9 relative to the housekeeping
protein actin. There was a correlation between MMP expression and decreased vein contraction. Also, significant increases in
MMP-2 and -9 immunostainingwere observed in IVC segments subjected to high 2 g tension for 24 hours. BothMMP-2 and
MMP-9 caused significant inhibition of Phe contraction in IVC segments.
Conclusions: In rat IVC, increases in magnitude and duration of wall tension is associated with reduced contraction and
overexpression of MMP-2 and -9. In light of our findings that MMP-2 and -9 promote IVC relaxation, the data suggest
that protracted increases in venous pressure and wall tension increase MMPs expression, which in turn reduce venous
contraction and lead to progressive venous dilation. (J Vasc Surg 2008;48:447-56.)
Clinical Relevance:Varicose veins is a major vascular disease that affects more than 25million adults in the United States.
The fundamental changes in varicose veins involve dilation, tortuosity, and structural changes in the vein wall, including
elastin fragmentation and disorganized smooth muscle. Venous hypertension is often associated with varicose veins and
advanced venous disease. Also,MMPs are over expressed in all layers of the varicose vein wall. The present study examined
possible relation between venous pressure, MMP expression, and venous tissue dysfunction in rat IVC. Although
differences in the physiologic behavior and structure of rat IVC and human veins make it difficult to extrapolate the
response of rat IVC to human veins, the results indicate that the magnitude and duration of vein wall tension have
significant impact on venous function and MMP expression. The data make it tempting to speculate that protracted
increases in venous pressure and wall stretch increase MMPs expression, which in turn produces venous dilation and
further increases in venous pressure, leading to a recalcitrant cycle and progressive venous dilation.From the Division of Vascular Surgery, Brigham and Women’s Hospital,a
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doi:10.1016/j.jvs.2008.03.004Varicose veins is a common vascular disease of the lower
extremity and is characterized by excessive dilation and
tortuousity of the venous system.1-3 The primary cause of
varicose vein formation is not clear; however, both vein
valve dysfunction and hydrostatic venous pressure appear to
play a critical role in the initiation and progression of the
disease.4-6 Although valve-refluxmay precede vein-dilatation,7
there is a significant body of evidence supporting the view
that vein dilation can precede venous reflux, and that
valvular dysfunction may be an epiphenomenon of vein
wall dilation.4,8-10 Clinical studies have demonstrated
that venous insufficiency can occur in varicosities without
axial reflux of the superficial, deep, or perforator veins,11
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cause connective tissue changes prior to valvular insuffi-
ciency.12 Also, studies have shown increases in matrix met-
alloproteinases (MMPs) in the venous wall and the plasma
of patients with varicose veins. Specifically, the expression
and/or activity of MMP-1, -2, -3, -9, -12, and -13 are
increased in varicose veins.13-17 Varicose veins are associ-
ated with increased expression of MMP-1 and -9 not only
in the adventitial fibroblasts, but also in the medial smooth
muscle and in endothelial cells.15 In varicose veins compli-
cated with thrombophlebitis, the content/activity of
MMP-1, -2, and -9 in the vein wall are significantly ele-
vated, which may cause extensive extracellular matrix re-
modeling and influence the mechanical properties of the
vein wall, and thereby predispose to further progression of
the disease.17
Previous studies have shown that mechanical stretch/
pressure in human endothelial cells from muscle and in
lung tissue subjected to high volume are associated with
overexpression of MMP-2.18-19 Also, the expression of
MMP-2, -9, and -14 is increased in fibroblasts, endothelial
cells, and smooth muscle cells from human arteries and
veins subjected to mechanical stretch.20-22 We have re-
cently demonstrated that MMP-2 induces significant relax-
ation of rat inferior vena cava (IVC), possibly through
smooth muscle cell hyperpolarization and activation of
large conductance Ca2-dependent K channel (BKCa), a
novel mechanism of MMP that may play a role in the early
stages of venous dilation and varicose vein formation.23-24
Although increases in both venous pressure and MMPs
have been implicated in the pathogenesis of varicose veins,
little is known regarding the link between mechanical
stretch of the vein wall, the MMPs expression in venous
tissue, the contractile function, and the venous dilation
associated with varicose veins. The objective of this study
was to test the hypothesis that an increase in venous pres-
sure/wall tension is associated with upregulation of specific
MMPs in the vein wall and venous smooth muscle dysfunc-
tion, leading to progressive venous dilation. We used rat
IVC segments to test: (1) whether increases in magnitude
and/or duration of vein wall tension are associated with
decreased vein contraction; (2) whether increased vein wall
tension is associated with increased expression of specific
MMPs; and (3) whether the specific MMPs expressed
during increases in wall tension cause inhibition of vein
contraction.
MATERIAL AND METHODS
Solutions and drugs. Physiological Krebs solution
contained (in mmol/L): NaCl 120, KCl 5.9, NaHCO3 25,
NaH2PO4 1.2, dextrose 11.5, CaCl2 2.5, MgCl2 1.2,
bubbled with 95% O2 and 5% CO2 and maintained at pH
7.4. High KCl (96 mmol/L) was prepared as Krebs solu-
tion with equimolar substitution of NaCl with KCl. Tested
compounds included phenylephrine (Phe), acetylcholine
(Ach), and angiotensin II (AngII) (Sigma, St. Louis, Mo),
MMP-2 and MMP-9 (recombinant human, active form,
Biomol, Plymouth Meeting, Pa), and tissue inhibitor met-alloproteinase-1 (TIMP-1) (recombinant human, Calbio-
chem, San Diego, Calif). All other chemicals were of re-
agent grade or better.
We examined the effects of recombinant humanMMPs
and TIMP-1 on rat tissues. MMP-2 and -9 and TIMP-1 are
highly conserved in human and rat tissues. MMPs (except
MMP-23) are highly homologous Zn2-dependent pro-
teinases that share the same conserved cysteine switch and
have a catalytic domain with a Zn2 binding motif that is
conserved in different species. Similarly, TIMPs have con-
served sequences in tissues from different species.25,26 In
our previous studies on rat aorta, we used recombinant
humanMMP-2 and -9.27 The commercial source (Biomol)
makes human recombinant MMP-2 and -9 and purified
mouse MMP-2. We opted to continue to use human
MMP-2 and -9 and human TIMP-1 because that would
allow us to compare the present results with our previous
findings with MMPs. Also, using human MMP-2 and -9
and TIMP-1 enhances the clinical relevance of the vasodi-
lator effects of MMPs. Additionally, our future goal is to
test the effects of MMPs on human veins, and it would be
advantageous to have reference data regarding their mini-
mal and maximal effective dose and time course in rat
tissues.
Animals and tissues. Male Sprague-Dawley rats (12
weeks, 250-300 g, Charles River Lab, Wilmington, Mass)
were euthanized by inhalation of CO2. Euthanasia was
judged by cessation of breathing and heart beats. The
abdominal cavity was opened, and the IVC was rapidly
excised, placed in Krebs solution, and carefully dissected
and cleaned of connective tissue under microscopic visual-
ization. The IVC was portioned into four 3 mm wide rings
in preparation for isometric contraction experiments. All
procedures followed the guidelines of the Institutional
Animal Care and Use Committee.
Isometric contraction. Each of the four IVC seg-
ments was suspended between two tungsten wire hooks,
one hook is fixed to a glass rod at the bottom of the tissue
bath and the other hook is connected to a Grass force
displacement transducer (FT03, Astro-Med Inc,WestWar-
wick, RI). The four vein segments were mounted on the
wire hooks in different tissue baths at no specific order to
minimize the effects of variability in tissue size on the
observed contractile response. Unless indicated otherwise,
vein segments were stretched under 0.5 g of basal tension
and allowed to equilibrate for 1 hour in a temperature
controlled, water-jacketed tissue bath, filled with 50 mL
Krebs solution continuously bubbled with 95%O2 5% CO2
at 37°C. The changes in isometric contraction were re-
corded on a Grass polygraph (Model 7D, Astro-Med). The
sensitivity of the contraction set-up was adjusted to detect
changes in vein contraction between 20 mg to 2 g. As in
many vascular beds, the diameter of vascular segments
tends to be greater in the proximal segments closer to the
heart. To correct for the effect of vein segment size and
diameter on the magnitude of contractile response, the
contraction was corrected for the tissue mass and presented
in mg/mg tissue weight. Using these settings, the maximal
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between 80.6 and 260.8 (mean  181.0  17.2 mg/mg
tissue, n  12). At the end of vein function experiments,
the tissues were gently padded dry and weighed, and stored
at80°C for immunoblot analysis and immunohistochem-
istry.
Basal tension-contraction relation. IVC segments
incubated in normal Krebs were subjected to increasing
basal tension of 0.0625, 0.125, 0.25, 0.5, 1, 2, and 3 g.
Following equilibration of IVC at the specific basal tension
for 30 minutes, the tissue bath solution was changed to 96
mmol/L KCl, and contraction was measured. The veins
were washed three times, 10minutes each in Krebs solution
prior to the next increase in basal tension and KCl contrac-
tion. We chose KCl to determine the tension-contraction
relation because KCl (96 mmol/L) produces maximum
and reproducible vein contraction that can be repeated
multiple times. Also, KCl-induced contraction is receptor-
independent, ie, not dependent on -adrenergic or AngII
receptors, thus avoiding possible receptor saturation or
desensitization with repeated agonist stimulation which
could significantly affect the maximum vein contraction at
the specific basal tension.
Prolonged basal tension and the KCl, Phe, and
AngII contraction. Vein segments were stretched under
0.5 g of basal tension and allowed to equilibrate for 1 hour.
The control contraction/relaxation properties of the IVC
segments were first determined. To determine the control
contraction, IVC segments were stimulated twice with 96
mmol/L KCl solution, followed by washing in Krebs solu-
tion three times 10 minutes each. To test the IVC relax-
ation function, the tissues were stimulated with Phe 105
mol/L to achieve a steady-state contraction, and then
treated with acetylcholine (Ach, 105 mol/L) to confirm
the presence of intact endothelium. The IVC segments
were then subjected to 0.5 g basal tension for 24 hours, or
2 g for 24 hours, or 2 g for 24 hours plus TIMP-1
(0.18-0.24 g/mL). The vein segments were randomly
assigned for a given experimental condition to reduce any
potential bias. After 24 hours of incubation at the specific
basal tension, the tissues were stimulated with 96 mmol/L
KCl, Phe (105 mol/L), and AngII (106 mol/L), and
the maximum contraction was measured.
The venous pressure corresponding to the low 0.5 g
and high 2 g basal tension was calculated using LaPlace’s
law that states that tension (force) is proportional to pres-
sure and as the tension increases, the pressure increases.
The pressure generated was calculated using the formula
T  Pxr/tw where T  tension (dyne/cm), P  pressure
(dyne/cm2), r  radius (cm), and tw  thickness of the
vessel wall. Assuming an average IVC diameter of 1.5 mm
as determined by histology and tw much less than the
radius, LaPlace’s law becomes T Pxr. Thus at 0.5 g basal
tension, the pressure generated is 4.9 mm Hg and at 2 g
tension the pressure generated is 19.6 mm Hg.
Effect of MMPs on Phe contraction. IVC segments
were subjected to 0.5 g tension for 1 hour. The tissues were
stimulated with Phe (105 mol/L) to elicit a contraction.When Phe-induced contraction reached steady-state,
MMP-2 or -9 was added and its effect was observed. Our
previous dose-response and time course experiments in rat
aorta demonstrated that MMP-2 and -9 at 1 g/mL
caused maximum aortic relaxation in 30 min.27 Also, our
previous experiments on rat IVC have shown time-dependent
MMP-2 induced relaxation that reached steady-state in
30 minutes.23 These MMP-2 and -9 concentrations are
physiologically consistent with the plasma and vein tissue
levels in human which range between 100 to 1000 ng/g
tissue (0.1 to 1 microg/ml).24,28 Therefore, in all experi-
ments 1 g/mL MMP-2 or MMP-9 was used and the
continuous trace of the effect of MMP on vein contraction
was recorded for at least 30 minutes. To compare quanti-
tatively the magnitude of Phe contraction in MMP-treated
and nontreated veins, the contraction trace was analyzed
for the magnitude of the response at selected time points at
5-minute intervals for 30 minutes.
Immunoblot analysis. Vein segments were homoge-
nized in a 2 mL homogenization buffer at 4°C. The ho-
mogenate was centrifuged at 10,000 g for 2 minutes, the
supernatant collected, and protein concentration was de-
termined. Tissue homogenate was subjected to electro-
phoresis on 8% SDS polyacrylamide gel then transferred
electrophoretically to nitrocellulose membranes (Bio-Rad,
Hercules, Calif). The membranes were incubated in 5%
dried non-fat milk in PBS-Tween buffer for 1 hour, then
incubated in the antibody solution (MMP-2 [1:500] or
MMP-9 [1:200] rabbit polyclonal IgG, Santa Cruz Bio-
technology, Santa Cruz, Calif) at 4°C for 24 hours. Actin
was used as internal control to standardize loading and
band intensities and was detected using anti--smooth
muscle actin monoclonal antibody (1:500,000, Sigma).
The membranes were washed in phosphate buffer solution
(PBS) then incubated in horseradish peroxidase-conju-
gated secondary antibody (1:1000) for 1.5 hours. The
membrane blots were washed with PBS, and visualized with
ECL detection system (Amersham, ArlingtonHeights, Ill).
The reactive bands corresponding to the specific MMP
were quantified by optical densitometry and analyzed using
ImageJ software.
Immunohistochemistry. Cryosections of IVC (6
m) were fixed in ice-cold acetone for 10 minutes. Endog-
enous peroxidase was quenched in 1.5%H2O2 solution and
nonspecific binding blocked in 10% horse serum. Sections
were treated with the specific MMP antibody. After rinsing
with PBS, sections were incubated with biotinylated-
secondary antibody, rinsed in PBS, and then incubated
with avidin-labeled peroxidase (VectaStain Elite ABC Kit,
Vector Lab, Burlingame, Calif). Positive labeling was visu-
alized using diaminobenzadine. Images were acquired on a
Nikon microscope with digital camera mount and analyzed
using Metamorph Imaging software.
Statistical analysis. The data from four to 15 mea-
surements in IVC segments from four to five rats were
analyzed and presented as means  SEM. Data were ana-
lyzed using ANOVA followed by Scheffe’s F test for com-
parison of multiple means. Student t test for unpaired and
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ences was considered significant if P  .05.
RESULTS
Tension-contraction relationship. IVC segments
subjected to step-wise increases in basal tension for short
duration (30 minutes) demonstrated incremental contrac-
tion to 96mmol/L KCl that reached amaximum at 0.25 to
0.5 g basal tension. Increases in basal tension to 1 g and 2 g
did not show any further increase in KCl contraction com-
pared with 0.5 g. When the basal tension was increased to
3 g, the KCl contraction was reduced significantly (n  8,
P .001) (Fig 1). Based on these results, we selected 0.5 g
as the normal control basal tension that produces maxi-
mum contraction. We also selected 2 g as the maximum
basal tension that still produces maximum contraction
without causing excessive tissue stretch.
Effect of prolonged tension on Phe contraction.
IVC segments subjected to 0.5 g basal tension for 1 hour
produced significant maximal contraction (127.4  11.6
mg/mg tissue) to the -adrenergic agonist Phe (105
mol/L) that was maintained at 73.4 11.6 mg/mg tissue
for 30 minutes. When the tissues were placed under 0.5 g
basal tension for 24 hours, a reduction in Phe contraction
was observed (57.3  17.8 mg/mg tissue, P  .03) com-
pared with IVC under 0.5 g tension for 1 hour. In tissues
subjected to 2 g basal tension for 24 hours, the Phe
contraction was further reduced to 40.8  7.3 mg/mg
tissue (Fig 2,A). In tissues subjected to 2 g basal tension for
24 hours but simultaneously treated with TIMP-1, the Phe
contraction was partially restored to (68.8  17.6 mg/mg
tissue, P  .047), suggesting the involvement of MMPs.
Effect of prolonged tension on AngII contraction.
To test whether the decreased IVC contraction with pro-
longed tension is related to specific changes in -adrenergic
Fig 1. Tension-potassium chloride (KCl) contraction relation-
ship. Inferior vena cava segments were subjected to increasing basal
tensions (0.0625 to 3 g) for 30 minutes, then stimulated with 96
mmol/L KCl. KCl contraction was not significantly different at
0.5 to 2 g basal tension. Further increase in wall tension to 3 g was
associated with significant decrease in contraction (P .01). Data
points represent means  SEM of measurements from eight ex-
periments.receptors, we examined the effects of prolonged tensionon another receptor-mediated contraction in response to
AngII. In IVC segments under 0.5 g basal tension for 1
hour, AngII (106 M) produced a transient response that
reached a peak of 122.5 13.0mg/mg tissue (Fig 2, B). In
tissues under 0.5 g basal tension for 24 hours, a reduction
in AngII contraction was observed (48.0  14.1 mg/mg
tissue, P .008) compared with tissues under 0.5 g tension
for 1 hour. The AngII contraction was further reduced in
tissues subjected to 2 g basal tension for 24 hours (24.0 
4.9 mg/mg tissue), and was partially restored in tissues
simultaneously treated with TIMP-1 (79.5  8.2 mg/mg
tissue, P  .002), further suggesting the involvement of
MMPs.
Effect of prolonged tension on KCl contraction.
To further test whether the decreased IVC contraction with
Fig 2. Effect of increases in basal tension on phenylephrine (Phe)-
and angiotensin II (AngII )-induced contraction. Inferior vena
cava segments were subjected to 0.5 g tension for 1 hour or 2 g
tension for 24 hours in the absence or presence of tissue inhibitor
of metalloproteinase-1 (TIMP-1). The tissues were stimulated with
Phe (105 mol/L) (A) or AngII (106 mol/L) (B) and the
contractile response was recorded. Data points represent means 
SEM of measurements from four experiments. *Significantly dif-
ferent (P .05) from contraction at 0.5 g for 1 hour basal tension.
§Significantly different (P  .05) from contraction at 2 g for 24
hours basal tension.prolonged tension is related to changes in specific recep-
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receptor-independent contraction in response to mem-
brane depolarization by KCl. KCl (96 mmol/L)-induced
contraction was not significantly different in IVC segments
subjected to 2 g tension compared with those subjected to
0.5 g basal tension for 1 hour (Fig 1). Experiments were
performed on vein segments that are identically incubated
under no tension or 0.5 g tension for 24 hr, and the results
were compared with vein segments incubated under 2 g
tension for 24 hours. KCl-induced contraction in tissues
incubated under no tension for 24 hours (162.4  26.3
mg/mg tissue) was not significantly different from the
initial control KCl-induced contraction (181.0  17.2
mg/mg tissue). The KCl induced response was reduced in
vein segments incubated under 0.5 g tension for 24 hours
(86.7 22.0mg/mg tissue) compared with control tissues
under 0.5 g tension for 1 hour. In comparison, the KCl
induced response was significantly reduced (P  .05) in
tissues incubated under 2 g tension for 24 hours (61.4 
10.0 mg/mg tissue) (Fig 3). These data demonstrate that
the magnitude of KCl contraction is reduced with increas-
ing amount of basal tension, and confirm that the applied
tension is the important variable in determining the
changes in contractile response. The KCl contraction ap-
peared to be partially restored in tissues under 2 g of tension
for 24 hours and simultaneously treated with TIMP-1
(114.8  25.8 mg/mg tissue), but the changes only ap-
proached statistical significance (P  .050) (Fig 3).
Immunoblot analysis for MMPs. Immunoblot anal-
ysis in rat IVC subjected to 0.5 g basal tension for 1 hour
Fig 3. Effect of increases in basal tension on KCl-induced con-
traction. Inferior vena cava segments were subjected to 0.5 g
tension for 1 hour, or 2 g tension for 24 hours in the absence or
presence of tissue inhibitor of metalloproteinase-1 (TIMP-1). The
tissues were stimulated with KCl (96 mmol/L) and the contractile
response was recorded. Data points represent the means SEM of
measurements from four experiments. *Significantly different (P
.05) from KCl contraction at 0.5 g 1 hour basal tension.revealed measurable amounts of both MMP-2 andMMP-9. When normalized to actin, the amount of
MMP-2 in the IVC appeared to be greater than that
ofMMP-9. In tissues subjected to 2 g tension for 24 hr, the
amount of MMP-2 and MMP-9 was markedly enhanced
(Fig 4). The relation between MMP expression and the
Phe- and KCl-induced contraction at 0.5 g for 1 hour and
2 g for 24 hours basal tension was constructed. A correla-
tion between MMP expression and the vein wall response
to Phe- and KCl was observed (Fig 5). Control experiments
indicated that in tissues under 0 g tension changing the
duration of the experiment alone (1 hour vs 24 hours) was
not associated with significant changes in MMP-2 expres-
sion as measured by immunoblots.
Some studies have shown that mechanical stretch can
affect actin expression in venous tissues in culture.29 How-
ever, these studies examined the effect of stretch on con-
tractile differentiation, and concluded that stretch stabilizes
the contractile smooth muscle phenotype. Also, in these
studies, the increase in stretch load caused an increase in
total actin protein over 3 to 7 days. In contrast, the present
experiments examined the changes in protein expression
over a 24-hour period. Also, the present actin immunoblots
did not reveal detectable variations in actin expression as
detected by the naked eye and the optical densitometry
measurements. These observations make it less likely that
variations in the levels of actin with stretch could have
biased the measurements of MMP/actin ratio.
Immunohistochemistry for MMPs. Immunohisto-
chemistry in sections of IVC suggested that both MMP-2
and MMP-9 are expressed in the three layers of the IVC
wall (Fig 6). Although immunohistochemistry is largely a
qualitative method, we attempted to measure the average
intensity of MMP staining to make it easier to discern the
differences in the MMP images (Table). Significant in-
creases inMMP-2 and -9 immunostaining were observed in
IVC subjected to 2 g basal tension for 24 hours compared
with tissues under 0.5 g basal tension. Also, a relative
increase in the MMP immunostaining in the smooth mus-
cle media could be observed in tissues under 2 g tension for
24 hours (Fig 6, Table). Control experiments indicated
that in tissues under 0 g tension changing the duration of
the experiment alone (1 hour vs 24 hours) was not associ-
ated with significant changes in MMP-2 expression as
measured by immunohistochemistry.
Effect of MMPs on IVC contraction. In a previous
study, we demonstrated that MMP-2 (1 g/ml) caused
significant relaxation of Phe contraction to 39.5 10.5% of
control contraction in 30 minutes (P  .029).23 In the
present experiments, MMP-9 (1 g/ml) caused similar
time-dependent relaxation of Phe-induced contraction in
IVC segments (Fig 7). Comparison of MMP-2 and
MMP-9 induced relaxation demonstrated no significant
difference in the time course or magnitude of IVC relax-
ation between MMP-2 and MMP-9 (P  .32).
We also tested the effect of TIMP-1, inhibitor of
MMP-2 activity, on tissues under 0.5 g load and found that
TIMP-1 alone did not cause any contractile response. On
the other hand, the inhibitory effects of MMP-2 on Phe-
.05).
JOURNAL OF VASCULAR SURGERY
August 2008452 Raffetto et alinduced contraction were prevented in IVC segments pre-
treated with TIMP-1 (Fig 7), confirming that the effects are
likely due to MMP activity and thereby supporting the
specificity of the MMP effects.
DISCUSSION
The main findings of the present study are: (1) IVC
segments subjected to high 2 g basal tension for prolonged
24 hours show significant reduction in Phe and AngII
contraction; (2) Phe and AngII contractions were partially
restored in vein segments under 2 g tension for 24 hours
and treated with TIMP-1; (3) high 2 g vein wall tension for
24 hours was associated with increased amount of MMP-2
and MMP-9; and (4) similar to our previous observation
with MMP-2, MMP-9 caused significant inhibition of Phe
contraction in IVC segments.
We investigated the relation between venous pressure/
wall tension, MMP expression, and venous tissue dysfunc-
tion. We first examined whether increases in the magnitude
of basal tension cause changes in venous contraction. We
found that 0.5 g basal tension for 30 minutes produced
maximal IVC contraction to KCl, and therefore 0.5 g was
used as the control basal tension. Also, increases in basal
tension up to 2 g did not change the maximal IVC contrac-
tion to KCl, and therefore 2 g was used as themaximal basal
tension that could be applied to the veins without causing
significant tissue damage/fatigue.
We then tested whether prolonged increases in vein
wall tension affect venous contraction. Phe activates
Fig 4. Immunoblot analysis for matrix metalloproteina
subjected to 0.5 g tension for 1 hour or 2 g tension fo
Western blot analysis using specific anti MMP-2 (1:500)
immunoreactive bands was normalized to the house-ke
eight to 15 measurements. *Significantly different (P -adrenergic receptors,30 and AngII activates angioten-sin type 1 receptors.31 We found that prolonged increases
in basal tension are associated with reduction in Phe-
induced IVC contraction, which may not be specific to
-adrenergic mediated responses as AngII-induced con-
traction was similarly reduced under these conditions.
These findings suggest that the decrease in vein contraction
following prolonged stretch is independent of the type of
receptor stimulated and may involve inhibition of a com-
mon signaling pathway downstream from receptor activa-
tion.
To determine whether the decreased vein contraction
with prolonged increases in vein wall tension involves in-
creases in MMP activity, we tested the effects of MMP
inhibitors. We have previously tested whether the inhibi-
tory effects ofMMPon vascular contraction can be reversed
by MMP-2/MMP-9 inhibitor IV and -2 macroglobu-
lin.27 Unfortunately, these MMP inhibitors exert an inhib-
itory effect on vascular contraction, possibly because they
bind Zn2 and other divalent cations such as Ca2, a major
determinant of vascular contraction, and hence, would
confound the results.27 We therefore tested the effects of
TIMP-1, inhibitor of gelatinases A and B.24,25 The obser-
vation that the reduced IVC contraction in tissues sub-
jected to prolonged basal tension was reversed in tissues
treated with TIMP-1, suggest possible involvement of
MMP-2 and -9. However, at least 26 MMPs have been
identified and classified into major subgroups including
interstitial collagenases, gelatinases, stromelysins, and
membrane-type MMPs (MT-MMPs). Other MMP sub-
MPs) in inferior vena cava (IVC). IVC segments were
ours. The tissues were rapidly frozen and prepared for
nti MMP-9 antibody (1:200). The optical density of the
protein actin. Data points represent means  SEM ofse (M
r 24 h
and a
epinggroups include matrilysins, enamelysin, and macrophage
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and -9, it could also bind to and inhibit membrane type-1
MMP (MT1-MMP), and perhaps other MMPs. Future
experiments should test the effects of selective MMP
monoclonal antibodies and siRNA and thereby further
elucidate the specific MMP(s) involved in the decreased
contraction associated with increased vein wall tension.
The present immunoblot analysis in IVC suggested
increased expression of MMP-2 and -9 during prolonged
increases in basal tension. Also, immunohistochemical
staining suggested localization of MMP-2 and -9 in the
three layers of the vein wall. Additionally, prolonged in-
Fig 5. Correlation betweenmatrix metalloproteinase (MMPs) ex-
pression and phenylephrine (Phe) and KCl contractile response.
Inferior vena cava segments were subjected to 0.5 g tension for 1
hour or 2 g tension for 24 hours. After eliciting the contractile
response to KCl (96 mmol/L) and Phe (105 mol/L), the vein
segments were frozen and prepared for Western blot analysis using
anti MMP-2 (1:500) and anti MMP-9 antibody (1:200). The
optical density of the immunoreactive bands was normalized to
actin. The relation between the amount of MMP-2 (A) or MMP-9
(B) and the contractile response to KCl and Phe was then con-
structed. Data points represent 15 measurements for MMP-2 and
eight measurements for MMP-9.creases in wall tension were associated with relative in-creases in MMP-2 and -9 in the vicinity of the smooth
muscle layer, suggesting an effect on the contractile cells.
Our data in the rat IVC are consistent with previous reports
that capillaries within the skeletal muscle subjected to me-
chanical stretch show increased MMP-2 mRNA transcrip-
tion.19 Also, cultured vascular smooth muscle cells from
mice and exposed to cyclic mechanical stretch demonstrate
an increase in MMP-2 mRNA.21 The observation that the
decreased IVC contraction during prolonged increases in
basal tension was reversed in tissues pretreated with
TIMP-1 suggests that the increased MMP amount is asso-
ciated with increased MMP activity. Future zymography
experiments would confirmwhether the decreased contrac-
tion in venous tissues exposed to prolonged increases in
tension reflect increases not only in the amount but also the
activity of MMPs.
The question remains as of how MMP expression and
changes in venous contraction could be interrelated. We
have previously shown that treatment of aortic strips with
MMP-2 and -9 did not cause significant changes in the
blood vessel structure or morphometry as determined by
H&E staining.27 Also, MMPs did not cause changes in the
elastin architecture as determined by Verohoff Von Gies-
son, suggesting minimal elastolytic effects of MMPs within
the acute time frame tested.27 The present data also showed
that the IVC was still responsive to Phe despite prolonged
tension, suggesting that -adrenergic receptors were still
intact. Also, the observation that prolonged tension was
associated with reduced contraction not only to Phe but
also to AngII indicates that the reduction in contraction is
not specific to a particular receptor. Furthermore, the Phe
and AngII contraction were restored in veins treated with
TIMP-1, suggesting that the reduction in contraction was
not due to reduction in the Phe or AngII receptors, but
rather due to increased MMP activity. It could be argued
that MMPs may proteolyze the membrane receptors. This
is unlikely because prolonged stretch was also associated
with reduced contraction to 96 mM KCl, which stimulates
receptor-independent Ca2 entry, supporting the conten-
tion that the reduced contraction in response to prolonged
increases in tension involves a post-receptor mechanism.
We have previously shown that MMP-2 and -9 inhibit
Phe-induced Ca2 influx in rat aortic segments.27 We have
also shown that MMP-2 causes significant inhibition of
Phe- and AngII-induced IVC contraction likely through a
post-receptor mechanism involving activation of plasmale-
mmal K channels, membrane hyperpolarization, and in-
hibition of Ca2 influx.23 The present findings confirm our
previous observations with MMP-2 and demonstrate that
MMP-9 cause significant inhibition of IVC contraction.
Several studies have demonstrated the presence of
MMPs in varicose veins.14,15 We found that MMP-9, sim-
ilar to MMP-2, caused time-dependent relaxation of Phe
induced contraction in rat IVC, suggesting that the effects
of MMPs on IVC relaxation are shared within the gelati-
nase family of MMPs. However, the present study does not
exclude the possibility that the presence/activation of
MMP-2 may lead to activation of other MMPs.32,33 Also,
ur to
ssue se
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some selectivity for someMMPs over others.23,25 This may
explain the present observation that TIMP-1 only partially
restored IVC constriction in tissues subjected to prolonged
increases in basal tension.
The present data suggest that MMP-2 and -9 have
acute venodilatory effect in addition to their known effects
on the extracellular matrix.24-26 We have previously shown
that the MMP-2 and MMP-9 induced inhibition of Phe
contraction in vascular segments is dose-dependent.27
Fig 6. Immunohistochemistry for matrix metalloprotein
or subjected to 2 g tension for 24 hours were rapidly froz
staining using anti MMP-2 or MMP-9 antibody (1:500)
(I), media (M), and adventitia (A) was measured. Hema
of the vessel wall. Data represent measurements from fo
Table. Amount and distribution of MMP-2 and MMP-9
24 hours
MMP-2
Control 2 g 24 h
Amount (% total area) 8.98  0.85 11.57  1.0
Distribution (pixels/m2)
Intima 3.61  1.02 6.96  0.8
Media 2.92  0.32 4.54  0.9
Adventitia 0.46  0.06 0.64  0.1
MMP, Matrix metalloproteinase.
Data represent means  SEM of measurements in four to five pictures of ti
aIndicates significant difference (P  .05).Also, our previous23 and present results demonstratethat the venodilator effects of MMP-2 and -9 are time-
dependent, within a total experimental time period of 30
min. Whether the acute venodilator effects of MMPs could
cause prolonged and progressive venous dilation in vivo
remains to be examined. Interestingly, a recent study has
evaluated morphologic changes in venous valves andMMP
expression in the vein wall in an in vivo rat model of venous
hypertension induced by a femoral artery-vein fistula.34
The study demonstrated an increase in the femoral vein
pressure (96  9 mm Hg) and progressive reflux 42 days
MMPs) in inferior vena cava (IVC). IVC segments at rest
d cryosections were prepared for immunohistochemical
amount of brown positive staining in the tunica intima
in and eosin staining was performed to test for integrity
five pictures of tissue sections. Total magnification 400.
IVC incubated at rest or under 2 g basal tension for
MMP-9
P Control 2 g 24 h P
.104 13.86  1.49 21.68  2.18 .018a
.045a 5.45  0.32 7.35  0.48 .011a
.147 3.99  0.68 6.59  0.86 .045a
.228 1.07  0.23 0.94  0.12 .630a
ctions.ase (
en, an
. The
toxylin rat
5
5
2
2after induction of arteriovenous fistula. The valves distal to
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the media and adventitia. Also, MMP-2 and -9 were signif-
icantly elevated after 21 and 42 days of venous hyperten-
sion.34 The present experiments have shown increased
MMP expression and decreased constriction in veins ex-
posed to high basal tension for 24 hours, suggesting that
biochemical and functional changes in the veins occur in as
early as one day of increased vein wall tension.
In the present study, we examined the effects of pro-
longed and consistent increases in vein wall tension on
MMP expression and vein function. Whether cyclic in-
creases in vein wall tension would differentially affect the
MMP expression profile and vein function remains to be
examined. Interestingly, smoothmuscle cells cultured from
human saphenous vein and subjected to static strain have
demonstrated increased MMP-2 and -9 mRNA expression
as well as proMMP-2 and -9 protein, while cyclic strain
(stretch) decreased the expression of MMPs.22 These data
in human saphenous vein cells indicate that constant stretch
is required for the overexpression of MMPs, which is con-
sistent with the increased venous hydrostatic pressure seen
in patients with chronic venous insufficiency.35
Although the IVC is less prone to varicosities, we used
the rat IVC because it can be rapidly dissected and consis-
tently responds to vasoconstrictors and vasodilators in a
reproducible fashion.23 Future studies on iliac and femoral
vein would increase the relevance to venous disease of the
lower extremity. While inherent differences in the physio-
logic behavior and structure of rat veins and human veins
Fig 7. Effects of matrixmetalloproteinase (MMPs) on phenyleph-
rine (Phe) contraction of inferior vena cava (IVC) segments. IVC
segments were subjected to 0.5 g tension for 1 hour and either
nontreated or pretreated with TIMP-1. The tissues were stimu-
lated with Phe (105 mol/L). When the Phe contraction reached
a steady state, the tissues were treated with MMP-2 or MMP-9 (1
g/ml) and the continuous trace of the effect of MMP on vein
contraction was recorded for at least 30 minutes. To compare
quantitatively the magnitude of Phe contraction in MMP and
TIMP-1 treated and nontreated veins, the contraction trace was
analyzed for the magnitude of the response at selected time points
at 5-minute intervals for 30 minutes. Data points represent means
SEM of measurements from five experiments. *Significantly differ-
ent (P  .05) from control.make it difficult to extrapolate the response of rat IVC tohuman veins, the results indicate that the magnitude and
duration of vein wall tension have significant impact on
venous function and MMP expression. We do not wish to
equate the results in rat IVC to human veins. On the other
hand, studies in the rat make it easier to obtain the veins
without delay and measure vein function rapidly. Also,
using the same rat strain, age and gender avoids potential
confounding factors and heterogeneity observed in dis-
carded samples of human veins. The availability of dis-
carded human veins with minimal surgical manipulation
is critical to test the effects of increases in human vein wall
tension on contraction and MMP expression, and to com-
pare vein function and MMP expression in “normal” and
varicose veins.
It is important to note that the 0.5 g and 2 g basal
tension used in this study correspond to 4.9 mm Hg and
19.6 mm Hg venous pressure, respectively. In normal
individuals of average 5-foot 10-inch height in the standing
position, the column of blood in the venous system reflects
a venous pressure at the ankle of 90 to 100 mm Hg. Thus,
the pressure generated at high 2 g basal tension is much less
than those seen in the lower extremity veins of humans in
the upright position. Also, in varicose veins as the perforat-
ing veins develop valve malfunction, the high pressures
developed in the deep veins with muscle contractions up to
250 mmHg are transmitted to the superficial veins. Apply-
ing the actual pressure generated in human varicose veins
would likely damage the IVC segments. We found that
increases in basal tension above 2 g caused significant and
irreversible reduction in IVC contraction (Fig 1), suggest-
ing structural changes and irreversible vein damage. There-
fore, high basal tensions above 2 g were not used to avoid
overstretch-induced structural changes that could compli-
cate the interpretation of the tension-MMP expression
relationship. Future studies in human vein specimens
would allow examination of tensions similar to those ob-
served in patients with varicosities/venous hypertension.
In conclusion, in rat IVC, increases in magnitude and
duration of wall tension are associated with reduced con-
traction and overexpression of MMP-2 and -9. Also,
MMP-9 induced IVC relaxation is consistent with our
previous findings with MMP-2. The present data lay the
ground for further experiments to test the possibility that
protracted increases in venous pressure/wall stretch in-
crease MMP-2 and MMP-9 expression, which in turn
produces venous dilation and further increases in venous
pressure, leading to a recalcitrant cycle and progressive
venous dilation.
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